肝细胞癌的进展:分子洞察力,组织学亚型和差异诊断
Wei Zheng1, Yulin Haw1, Hanlin L Wang2
1Department of Pathology, Emory University School of Medicine, Atlanta, GA.
Advances in anatomic pathology
|April 25, 2025
概括
最近的进展通过分子洞察力,组织学和具有挑战性的活检解释来改善肝细胞癌 (HCC) 诊断. 这些发现提高了识别和理解这种肝癌的精度.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 遗传学 是一个遗传学.
背景情况:
- 肝细胞癌 (HCC) 诊断已经显著发展.
- 关键的进展包括分子洞察力,组织学和活检解释.
研究的目的:
- 提供关于HCC诊断进展的最新概述.
- 强调这些方面在精确诊断中的集体作用.
主要方法:
- 对驱动基因突变 (例如,TERT促进体,CTNNB1,TP53) 和染色体异常的分子见解的审查.
- 分析不同的组织学亚型和与前体/良性病变的区别.
- 对解释具有挑战性的活检样本策略的评估.
主要成果:
- 发现驱动突变和染色体变异有助于恶性瘤的识别.
- 识别形态分子HCC亚型需要综合诊断方法.
- 从良性病变区分HCC需要多模式策略 (形态,IHC,分子).
结论:
- 综合组织学和分子发现对于准确的HCC诊断和预后至关重要.
- 边缘性肝细胞瘤需要全面的策略.
- 最近的进展共同提高了HCC的精确诊断.
关键词:
HCA HCA 的意思是什么?在HCC中,HCC是HCC.HGDN HGDN 的意思肝细胞癌是肝细胞癌.活组织活检边缘性肝细胞性瘤肝细胞腺瘤是一种肝细胞腺瘤.高度的发育不良结节.分子测试试验 分子测试小型类型 亚型 类型更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
590
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
